Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Prostanoid EP4 agonists for ocular disorders emerge from Merck Frosst R&D

Dec. 21, 2005

New antiinfective compounds revealed

Dec. 21, 2005

New treatments for urological disorders claimed in recent Tanabe Seiyaku and Eisai patents

Dec. 21, 2005

Norepinephrine reuptake inhibitors for ADHD emerge from Pfizer R&D

Dec. 20, 2005

Recent patents cover novel treatment options for cancer

Dec. 20, 2005

Novel agents with potential for treatment of pain described

Dec. 19, 2005

Recent patents report new therapeutic agents for metabolic disorders

Dec. 19, 2005

Recent patents cover novel treatment options for cancer

Dec. 16, 2005

Novel treatment options for inflammatory disorders claimed in recent patents

Dec. 16, 2005

Companies patent compounds for diabetes, dysmenorrhea, male contraception, etc.

Dec. 16, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...